Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the second-highest quintile among peers.
Brown Capital Mgmt Intl All Com Inv BCIIX
- NAV / 1-Day Return 17.63 / +0.34 %
- Total Assets 88.5 Mil
-
Adj. Expense Ratio
- Expense Ratio 1.250%
- Distribution Fee Level High
- Share Class Type No Load
- Category Foreign Large Growth
- Investment Style Large Growth
- Min. Initial Investment 5,000
- Status Open
- TTM Yield 0.00
- Turnover 12%
USD | NAV as of Oct 04, 2024 | 1-Day Return as of Oct 04, 2024, 10:12 PM GMT+0
Morningstar’s Analysis BCIIX
Will BCIIX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 37.5
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Icon PLC | 4.89 | 3.4 Mil | Healthcare |
Cochlear Ltd | 4.70 | 3.3 Mil | Healthcare |
Novo Nordisk A/S Class B | 4.69 | 3.3 Mil | Healthcare |
Givaudan SA | 3.97 | 2.8 Mil | Basic Materials |
First American Treasury Obligs D | 3.66 | 2.6 Mil | Corporate |
The Descartes Systems Group Inc | 3.50 | 2.5 Mil | Technology |
CyberArk Software Ltd | 3.42 | 2.4 Mil | Technology |
Novonesis AS Class B | 3.34 | 2.4 Mil | Basic Materials |
Carl Zeiss Meditec AG | 3.12 | 2.2 Mil | Healthcare |
MercadoLibre Inc | 2.97 | 2.1 Mil | Consumer Cyclical |